TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest announcement is out from Belluscura PLC ( (GB:BELL) ).
Belluscura PLC has appointed Guy Peters as a non-executive director, bringing his extensive experience in corporate finance and business development to the board. This appointment comes at a crucial time as the company evaluates funding options to strengthen its capital position, following the expiration of an exclusivity period with a potential acquirer. The company is considering a revised funding proposal from Omaha Value, Inc. and AI Ventures, Inc., but there is no certainty that the fundraising will be completed. The ongoing funding discussions have delayed the finalization of the 2024 Annual Report and Accounts, resulting in the continued suspension of trading in the company’s shares on AIM.
More about Belluscura PLC
Belluscura PLC is a UK-based medical device company specializing in the development of oxygen enrichment technology. The company aims to enhance health and economic outcomes for patients, healthcare providers, and insurance organizations through its innovative oxygen technologies.
Average Trading Volume: 1,907,820
Technical Sentiment Signal: Strong Sell
Current Market Cap: £3.01M
Learn more about BELL stock on TipRanks’ Stock Analysis page.